For KRAS mutations with frequency ≥1%, the concordance between tumor center and invasion front and between primary tumor and metastasis was 94.7% and 90.9%, respectively, implying the absence of heterogeneity in KRAS mutations (S4 Fig). This evidence concerns the gene KRAS and neoplasm.